BioCardia to Present at the LD Micro 500 Virtual Conference on September 1, 2020
August 26, 2020 07:00 ET
|
BioCardia, Inc.
SAN CARLOS, Calif., Aug. 26, 2020 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies today...
AlloVir to Present at the Morgan Stanley 18th Annual Global Healthcare Conference
August 25, 2020 07:30 ET
|
AlloVir Inc.
CAMBRIDGE, Mass., Aug. 25, 2020 (GLOBE NEWSWIRE) -- AlloVir, Inc. (Nasdaq: ALVR), a late clinical-stage cell therapy company, will present a corporate overview at the virtual Morgan Stanley 18th...
Incysus Therapeutics Announces Name Change to IN8bio, Inc.
August 24, 2020 07:00 ET
|
IN8bio, Inc.
NEW YORK, Aug. 24, 2020 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on delivering innovative gamma-delta (γδ) T cell immunotherapies for the...
Immatics weitet klinisches Studienprogramm für adoptive Zelltherapien auf Europa aus
August 18, 2020 07:00 ET
|
Immatics N.V.
Tübingen, Deutschland und Houston, Texas, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Der erste Patient in Deutschland wurde im Rahmen der Immatics‘ ACTengine® IMA202-101 Studie behandeltDie deutsche...
Immatics Announces European Clinical Expansion of its Adoptive Cell Therapy Programs
August 18, 2020 07:00 ET
|
https://immatics.com/
Tuebingen, Germany and Houston, Texas, Aug. 18, 2020 (GLOBE NEWSWIRE) -- First patient has been treated in Germany in Immatics’ ACTengine® IMA202-101 trialGerman regulatory agency,...
FibroGenesis Reports Breakthrough in Prevention of COVID-19 Blood Clotting
August 12, 2020 10:07 ET
|
FibroGenesis
HOUSTON, Aug. 12, 2020 (GLOBE NEWSWIRE) -- FibroGenesis, a clinical stage company developing fibroblast based therapeutic solutions for unmet medical needs, announced today new data supporting...
Avobis Bio and Vineti announce strategic collaboration to support new implantable cell therapies addressing debilitating conditions
August 11, 2020 09:00 ET
|
Vineti
NEWARK, Del. and SAN FRANCISCO, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Today, Avobis Bio, LLC (Avobis Bio), a clinical-stage regenerative therapy company specializing in the development of implantable...
Abeona Therapeutics Reports Second Quarter Financial Results and Business Updates
August 10, 2020 16:01 ET
|
Abeona Therapeutics Inc.
Additional patients dosed in RDEB, MPS IIIA and MPS IIIB clinical programs General alignment with CHMP on plans for EU registration of ABO-102 for MPS IIIA Data from RDEB and MPS III programs...
Incysus Therapeutics to Present at Solebury Trout Private Company Showcase
August 07, 2020 08:35 ET
|
Incysus Therapeutics, Inc.
NEW YORK, Aug. 07, 2020 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a clinical-stage biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell...
BioCardia To Conduct Mid-Year Conference Call and Corporate Update August 13, 2020
August 07, 2020 08:00 ET
|
BioCardia, Inc.
SAN CARLOS, Calif., Aug. 07, 2020 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today...